Delivery Order SPE2DB22D1106-SPE2DB24FFGZ6

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,075.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025,...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,952.76 delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company, on August 26, 2024, with a completion date of August 27, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The $1,392.30 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 14, 2025 with a completion date of May 15, 2025. The contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products to the Defense Logistics Agency (DLA), a defense agency. The $5,091.25 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2025. The award has an ultimate completion date of July 7, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,812.19. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The $2,477.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 28, 2024. This award is a part of Amerisourcebergen's broader federal contract portfolio, which includes Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The $9,012.76 firm fixed price delivery order was awarded on June 20, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a performance period ending on June 23, 2025. The contract is not set aside and was awarded as a delivery order. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4565481150 Epinephrine 0.3 mg Auto-Injectors to the Defense Logistics Agency (DLA), a civilian agency of the U.S. Department of Defense. The $1,495.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 16, 2024, with a completion date of August 19, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $11,803.92 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFGZ6
    Delivery Order

This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,473.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure essential medical supplies and medications to support military treatment facilities and programs worldwide. The contract has an ultimate completion date of August 16, 2024 and does not utilize any set-aside designations.

Generated 11/14/24, 9:24 AM